ERBB2 and breast carcinoma: A meta-analysis performed by Spring et al. showed a significant correlation between pCR and event-free survival or overall survival in NAC, particularly in human epidermal growth factor receptor 2-positive (HER2 +) and triple negative (TN) breast cancer [4].